definiens: or 1.39 means all activities that relate to ( a ) obtaining or maintaining Regulatory Approval of aLicensed Product or [COMPANY] Combination Product for one or more indications or ( b ) developing the process for theManufacture of clinical and commercial quantities of a Licensed Product or a [COMPANY] Combination Product . Thisincludes ( i ) the conduct of Nonclinical Studies and Clinical Trials ( including Required Phase 4 Clinical Trials ) and(ii ) the preparation, submission, review and development of data or information in support of a submission to aRegulatory Authority to obtain or maintain Regulatory Approval of a Licensed Compound, Licensed Product, or GileadCombination Product, as applicable, including the services of outside advisors in connection therewith, including itslegal counsel and regulatory consultants, but excludes ( A ) Commercialization and ( B ) the Manufacture andaccumulation of commercial inventory of a Licensed Product or [COMPANY] Combination, as applicable . has acorrelative meaning